Cengild Medical Berhad (KLSE:0243) — Market Cap & Net Worth
Market Cap & Net Worth: Cengild Medical Berhad (0243)
Cengild Medical Berhad (KLSE:0243) has a market capitalization of $40.78 Million (RM162.42 Million) as of September 17, 2026. Listed on the KLSE stock exchange, this Malaysia-based company holds position #22757 globally and #526 in its home market, demonstrating a -2.50% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Cengild Medical Berhad's stock price RM0.20 by its total outstanding shares 832912600 (832.91 Million). Also see Cengild Medical Berhad asset portfolio for a full breakdown of the balance sheet.
Cengild Medical Berhad Market Cap History: 2022 to 2026
Cengild Medical Berhad's market capitalization history from 2022 to 2026. Data shows change from $105.04 Million to $40.78 Million (-16.91% CAGR). Also see Cengild Medical Berhad (0243) cash conversion ratio for how efficiently the company converts equity into cash flow.
Cengild Medical Berhad Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Cengild Medical Berhad's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Cengild Medical Berhad (0243) share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.59x
Cengild Medical Berhad's market cap is 0.59 times its annual revenue
Latest Price to Earnings (P/E) Ratio
4.26x
Cengild Medical Berhad's market cap is 4.26 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $105.04 Million | $64.44 Million | $9.39 Million | 1.63x | 11.19x |
| 2023 | $68.23 Million | $70.28 Million | $13.29 Million | 0.97x | 5.13x |
| 2024 | $57.51 Million | $66.82 Million | $11.08 Million | 0.86x | 5.19x |
| 2025 | $47.05 Million | $80.00 Million | $11.06 Million | 0.59x | 4.26x |
Competitor Companies of 0243 by Market Capitalization
Companies near Cengild Medical Berhad in the global market cap rankings as of September 17, 2026. Review how tangible is Cengild Medical Berhad's equity to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Cengild Medical Berhad by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #288 globally with a market cap of $91.34 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #911 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #1001 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1234 globally with a market cap of $20.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #288 | HCA Healthcare, Inc. | NYSE:HCA | $91.34 Billion | $423.82 |
| #911 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €45.39 |
| #1001 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1234 | Tenet Healthcare Corporation | NYSE:THC | $20.93 Billion | $260.85 |
Cengild Medical Berhad Historical Marketcap From 2022 to 2026
Between 2022 and today, Cengild Medical Berhad's market cap moved from $105.04 Million to $ 40.78 Million, with a yearly change of -16.91%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | RM40.78 Million | -13.33% |
| 2025 | RM47.05 Million | -18.18% |
| 2024 | RM57.51 Million | -15.72% |
| 2023 | RM68.23 Million | -35.04% |
| 2022 | RM105.04 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Cengild Medical Berhad was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $40.78 Million USD |
| MoneyControl | $40.78 Million USD |
| MarketWatch | $40.78 Million USD |
| marketcap.company | $40.78 Million USD |
| Reuters | $40.78 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Cengild Medical Berhad
Cengild Medical Berhad, an investment holding company, operates a medical center in Malaysia. The company offers various care and treatment consultant services for gastrointestinal and liver diseases, morbid obesity, and oncology and urological conditions; general cardiology and gynecology assessment; gastroenterology and hepatology; anesthesiology, general surgery, internal medicine, and radiolo… Read more